Latest profit margin for Catalent: -9.34% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2024
Trailing 12 months ending Sep 2024
The latest profit margin for CTLT is -9.34% as of September 2024. That compares with -22.36% in the prior-year period — up 58.2% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Catalent's historical trend and sector peers before judging valuation or financial health.
Over the past year, CTLT's profit margin moved from -22.36% to -9.34% — a 58.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Catalent's valuation or profitability profile.
Against Healthcare companies, CTLT currently prints -9.34% for profit margin, while the sector average sits near 21.34%. That is roughly 143.8% below the sector mean. Large gaps often invite a closer look at Catalent's growth, margins, and balance sheet.
Profit Margin shows how effectively Catalent converts resources into returns. At -9.34%, CTLT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -22.36% in the prior-year period — up 58.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CTLT's profit margin (-9.34%), review year-over-year change from -22.36%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.